A RIVA-DM Subanalysis Investigating Patients With Nonvalvular Atrial Fibrillation and Type 2 Diabetes Aged Under Versus Over 80 Years

BACKGROUND: Advanced age and type 2 diabetes (T2D) are common in patients with nonvalvular atrial fibrillation (NVAF). We evaluated the impact of age on the effectiveness and safety of rivaroxaban versus warfarin in this population. METHODS: We analyzed electronic health record data from November 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Coleman, Craig I., Costa, Olivia S., Brescia, Christopher W., Vardar, Burcu, Abdelgawwad, Khaled, Hofmeister, Lucas, Sood, Nitesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666855/
https://www.ncbi.nlm.nih.gov/pubmed/36377242
http://dx.doi.org/10.1177/10760296221133083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666855/
https://www.ncbi.nlm.nih.gov/pubmed/36377242
http://dx.doi.org/10.1177/10760296221133083

Ejemplares similares